home / stock / mrtx / mrtx articles

MRTX Articles, Mirati Therapeutics Inc. - From 10/17/23

Stock Information
Company Name: Mirati Therapeutics Inc.
Stock Symbol: MRTX
Market: NASDAQ
Website: mirati.com
Menu
MRTX MRTX Quote MRTX Short MRTX News MRTX Articles MRTX Message Board
Get MRTX Alerts

News, Short Squeeze, Breakout and More Instantly...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SP, OLK, ORTX, MRTX | Benzinga

NEW YORK, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potentia...
Moore Kuehn Encourages SP, ORTX, MRTX, and SRT Investors to Contact Law Firm | Benzinga

NEW YORK, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown N...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MRTX, NWLI, PWFL | Benzinga

NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potentia...

Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Gainers ParaZero Technologies Ltd. (NASDAQ: PRZO) shares jumped 106% to $2.3901 after the company announced an Australian regulator approved first...
Stocks Halt Gains, Oil, Treasuries Rally As Investors React to Israel-Hamas Conflict: What's Driving Markets Monday? | Benzinga

Markets kicked off the week with heightened volatility due to the ongoing conflict between Israel and the Palestinian militant group Hamas. Israel...

Bristol Myers Squibb Strengthens Oncology Portfolio With Mirati Therapeutics' $5B Deal | Benzinga

Bristol Myers Squibb & Co (NYSE: BMY) has agreed to acquire Mirati Therapeutics Inc (NASDAQ: MRTX) for $58.00 per share in cash,...

S&P 500, Nasdaq Set For Bleak Start To Week As Middle East Tensions Dampen Risk-On Mood: Earnings, Inflation Data In Focus | Benzinga

The market may open the week on a cautious note due to escalating tensions in the Middle East caused by violent rocket attacks from the Palestinian...
Tesla, Mirati Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session | Benzinga

U.S. stock futures traded lower this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session. TPG...

Amgen's Adcomm Meeting Paves Way To Launch Boost For Mirati Therapeutics' Lung Cancer Drug: Analysts | Benzinga

According to a report on Thursday, French pharma company Sanofi SA (NASDAQ: SNY) is reportedly exploring a potential acquisition of cance...

FDA AdCom Gives Thumbs Down To Late-Stage Data For Amgen's Lumakras In Advanced Form Of Lung Cancer (UPDATED) | Benzinga

Editor's note: The headline of this story has been updated to make clearer the FDA vote is on late-stage Lumakras data.  FDA advisers conc...
Previous 10 Next 10